The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.6032
Abstract: BACKGROUND Assessment of Ki67 by immunohistochemistry (IHC) has limited utility in clinical practice owing to analytical validity issues. According to International Ki67 Working Group (IKWG) guidelines, treatment should be guided by a prognostic test in… read more here.
Keywords: ki67; canassist breast; risk; cab ... See more keywords